MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dysarthria"

  • 2024 International Congress

    Passive smartphone speech monitoring in isolated rapid eye movement sleep behaviour disorder

    V. Illner, M. Novotny, T. Kouba, T. Tykalova, M. Simek, P. Sovka, J. Svihlik, E. Ruzicka, K. Sonka, P. Dusek, J. Rusz (Prague 6, Czech Republic)

    Objective: We aimed to design and test the sensitivity of a fully-automated and noise-resistant smartphone-based system that can unobtrusively screen for prodromal parkinsonian speech disorder…
  • 2024 International Congress

    Effects on Speech After the Use of Swallow Against Resistance Exercise Device in Parkinson’s Disease Patients

    R. Lee, H. Hassan, E. Jackowiak, R. Brennan, M. Kern, R. Shaker (Milwaukee, USA)

    Objective: To evaluate the effect on speech after a strength training exercise targeting the swallowing biomechanics in Parkinson’s disease (PD) patients. Background: Dysarthria and dysphagia…
  • 2024 International Congress

    Examining the Effects of Deep Brain Stimulation on Speech in Parkinson’s Disease

    H. Kabakoff, A. Mogilner, M. Pourfar, A. Flinker (Brooklyn, USA)

    Objective: The current goal is to use pilot data to explain speech changes in patients with Parkinson’s disease (PD) who have Deep Brain Stimulation (DBS)…
  • 2024 International Congress

    Detecting impulsivity through speech in patients with Parkinson’s Disease: A principle proof study

    T. Thies, E. Mallick, S. Jost, J. Tröger, M. Barbe (Cologne, Germany)

    Objective: To identify speech biomarkers to assess impulsivity in patients with Parkinson's disease (PwPD). Background: Although PD mainly presents with motor symptoms, the burden of…
  • 2024 International Congress

    Craniofacial Myoclonus: A Disabling Complication of Amantadine Therapy

    S. Bhushan, Mph, S. Brillman, Md (Palo Alto, USA)

    Objective: We describe a patient who developed amantadine-induced craniofacial myoclonus with speech impairment. Few cases have been reported [1], thus we offer an additional case…
  • 2024 International Congress

    The Effect of Genotype on Voice & Swallowing in Parkinson’s Disease: A Parkinson’s Progression Markers Initiative Study

    M. Dumican, T. Reyers, A. Malczewski (Kalamazoo, USA)

    Objective: The objectives of this project were twofold: 1. Determine how genotypes of Parkinson’s Disease (PD) affect voice & swallowing function, and 2. Examine how…
  • 2024 International Congress

    Breaking Barriers to Offer Evidence-Based Services for Patients with Parkinson’s Disease in South Africa

    S. Govender, S. Haffejee (Johannesburg, South Africa)

    Objective: To provide evidence-based services for patients with Parkinson’s disease considering the burden of disease in South Africa (SA) and access, socio economic and technology…
  • 2024 International Congress

    Effect of Levodopa therapy in Hypokinetic Dysarthria in Parkinson’s Disease

    E. Smaoui, N. Farhat, S. Daoud, K. Moalla, N. Bouattour, M. Damak, C. Mhiri (Sfax, Tunisia)

    Objective: The objective of this study was to assess the possible changes in acoustic speech parameters in a cohort of PD patients after acute levodopa…
  • 2024 International Congress

    Correlating Dysarthria with MRI Findings in Temporal Lobe Glioma: Impact of Steroid Therapy on Cerebral Edema

    D. Valle, L. Valad, S. Jiang, B. Carr (Gainesville, USA)

    Objective: Examine the relationship between dysarthria and MRI findings in a patient with left posterior mesial temporal lobe glioma and further evaluate the role of corticosteroid therapy in mitigating associated cerebral…
  • 2024 International Congress

    Speech Biomarkers for Dysarthria in Parkinson’s Disease — Clinical Validation Across two Languages

    J. Tröger, E. Baykara, F. Dörr, J. Rusz, J R. Orozco-Arroyave (Saarbrücken, Germany)

    Objective: To identify reliable speech biomarkers for assessing dysarthria in individuals with Parkinson's disease (PD) and ensuring their clinical validity across languages. Background: This study…
  • 1
  • 2
  • 3
  • …
  • 15
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • An atypical and interesting feature of Parkinson´s disease
  • #24752 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • An atypical and interesting feature of Parkinson´s disease
  • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley